Amyris, Inc. is an American synthetic biotechnology and renewable chemical company that serves the specialty chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.

According to the law firm press release, the lawsuit alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris’ decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On August 8, 2017, the Court issued an Order appointing Lead Plaintiff and Counsel.

On September 20, 2017, Plaintiff filed a Notice voluntarily dismissing this action. The Court granted an Order of Dismissal without prejudice on September 21.